Fulminant type 1 diabetes - an important subtype in East Asia

被引:84
作者
Imagawa, Akihisa [1 ]
Hanafusa, Toshiaki [2 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan
[2] Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka 569, Japan
关键词
idiopathic; epidemiology; human leukocyte antigen (HLA); virus; cytotoxic T lymphocyte antigen (CTLA)-4; SOCIETY COMMITTEE; NATIONWIDE SURVEY; MELLITUS; ONSET; PREVALENCE; ANTIBODIES; EXPRESSION; ELEVATION; PROPOSAL; PATIENT;
D O I
10.1002/dmrr.1236
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fulminant type 1 diabetes is defined as a subtype of type 1 diabetes with a remarkably acute onset. A nationwide survey identified that this variant accounts for approximately 20% of acute-onset type 1 diabetic patients in Japan. Recent studies indicate that this is not a minor subtype in other East Asian countries. As genetic factors, we revealed association of HLA-DR-DQ, HLA-B and CTLA-4 to fulminant type 1 diabetes. As an environmental factor, viral infection would contribute to the development of this subtype. Cellular infiltration to islets was detected soon after the onset but not observed 1 month after the onset. Macrophages and T cells were the main components of the infiltrates. Enterovirus RNA and Toll-like receptor-3 expression, a signature of viral infection, was also observed. These findings suggest that viral infection in the susceptible individual might trigger antiviral immune response and that pancreatic beta cells are rapidly destroyed through the accelerated immune reaction. Copyright (C) 2011 John Wiley & Sons, Ltd.
引用
收藏
页码:959 / 964
页数:6
相关论文
共 32 条
[1]  
Akatsuka Hajime, 2009, Diabetes Res Clin Pract, V84, pe50, DOI 10.1016/j.diabres.2009.03.009
[2]   Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection [J].
Chiou, CC ;
Chung, WH ;
Hung, SI ;
Yang, LC ;
Hong, HS .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (02) :S14-S17
[3]   Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes [J].
Cho, Y. M. ;
Kim, J. T. ;
Ko, K. S. ;
Koo, B. K. ;
Yang, S. W. ;
Park, M. H. ;
Lee, H. K. ;
Park, K. S. .
DIABETOLOGIA, 2007, 50 (11) :2276-2279
[4]   Case of fulminant type 1 diabetes associated with significant elevation of mumps titers [J].
Goto, Atsushi ;
Takahashi, Yoshihiko ;
Kishimoto, Miyako ;
Nakajima, Yoshifumi ;
Nakanishi, Koji ;
Kajio, Hiroshi ;
Noda, Mitsuhiko .
ENDOCRINE JOURNAL, 2008, 55 (03) :561-564
[5]  
Hanafusa Toshiaki, 2008, Journal of the Japan Diabetes Society, V51, P531
[6]  
Hanafusa Toshiaki, 2005, Journal of the Japan Diabetes Society, V48, pA1
[7]   Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners [J].
Hanafusa, Toshiaki ;
Imagawa, Akihisa .
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (01) :36-45
[8]  
Haseda F, 2010, DIABETES, V59, pA362
[9]   Fulminant Type 1 diabetes mellitus associated with acute hepatitis A [J].
Hwang, Y. -C. ;
Jeong, I. -K. ;
Chon, S. ;
Oh, S. ;
Ahn, K. J. ;
Chung, H. Y. ;
Woo, J. -T. ;
Kim, S. -W. ;
Kim, J. -W. ;
Kim, Y. S. .
DIABETIC MEDICINE, 2010, 27 (03) :366-367
[10]   Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus (vol 48, pg 294, 2005) [J].
Imagawa, A. ;
Hanafusa, T. ;
Uchigata, Y. ;
Kanatsuka, A. ;
Kawasaki, E. ;
Kobayashi, T. ;
Shimada, A. ;
Shimizu, I. ;
Maruyama, T. ;
Makino, H. .
DIABETOLOGIA, 2008, 51 (03) :524-526